Corebridge Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,384	Closed	-$987K	–	1518
2025 Q1	$987K	Buy	9,384 +109	+1%	+$11.5K	0.01%	1260
2024 Q4	$994K	Sell	9,275 -544	-6%	-$58.3K	0.01%	1330
2024 Q3	$983K	Sell	9,819 -48	-0.5%	-$4.8K	0.01%	1368
2024 Q2	$831K	Buy	+9,867	New	+$831K	﹤0.01%	1431